Lindbrook Capital, LLC Sangamo Therapeutics, Inc Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$1.66 - $3.67 $3,250 - $7,185	-1,958 Reduced 53.53%	1,700 $2,000
Q4 2022 Jan 24, 2023	BUY	$2.77 - $5.07 $9,922 - $18,160	3,582 Added 4713.16%	3,658 $0
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $324 - $485	76 New	76 $0
Q2 2022 Aug 01, 2022	SELL	$3.28 - $6.21 $291 - $552	-89 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$5.23 - $7.82 $465 - $695	89 New	89 $1,000
Q4 2019 Jan 27, 2020	SELL	$8.03 - $11.7 $1,204 - $1,755	-150 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$8.75 - $13.03 $1,312 - $1,954	150 New	150 $1,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.